Page 14 - ASPIRE JANUARY 2023 Volume 8 / Issue 1

CHINA
emerging infectious
diseases in assisted
reproduction settings
By Dr Junhao Yan Country Representative
According to latest global data, COVID-19 remains an ongoing pandemic and is highly likely to coexist with us in the future.
Up to date, the immunisation campaign has covered more than 1.34 billion people, of whom 1.27 billion have been fully vaccinated.
The pandemic in China has been effectively controlled and all work has basically returned to normal. However, due to the complexities of assisted reproductive treatment, outpatient visits increase the risk of infection and therefore they present a degree of clinical challenge.
In response, we have formulated a series of expert guidelines with comprehensive reference material for reproductive health and maternal and child safety. Therefore, we have optimised the management system of major emerging infectious diseases in assisted reproduction and other medical institutions.
Junhao Yan
Following strict prevention and control protocols, the 15th National Reproductive Medicine Academic Conference of the Chinese Medical Association was successfully held in August 2022.
A range of topics addressed at the conference included:
• the progress and long-term development of assisted reproductive technology;
• application of artificial intelligence in assisted reproduction;
• laboratory equipment and management processes; and
• automation and intelligent research.
The conference attracted more than 2,025 papers with speakers including Professor Linda C. Giudice, President of the International Reproductive Medicine Alliance, Professor Takeshi Kuramoto, President of the Japanese Society for Reproductive Medicine, and many other experts from home and abroad.
We plan to hold the 16th National Reproductive Medicine Conference of the Chinese Medical Association in Nanjing in the first half of 2023.
Linda Giudice
12
Guidelines on managing